RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
about
MAPKs in development: insights from Dictyostelium signaling pathwaysRedundancy in the World of MAP Kinases: All for OneERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?The N-terminal domain of ERK1 accounts for the functional differences with ERK2Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cellsDissecting genealogy and cell cycle as sources of cell-to-cell variability in MAPK signaling using high-throughput lineage tracking.Immunolocalization of dually phosphorylated MAPKs in dividing root meristem cells of Vicia faba, Pisum sativum, Lupinus luteus and Lycopersicon esculentum.Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.Effects of estrogens and bladder inflammation on mitogen-activated protein kinases in lumbosacral dorsal root ganglia from adult female ratsCordyceps bassiana inhibits smooth muscle cell proliferation via the ERK1/2 MAPK signaling pathway.MAP kinases have different functions in Dictyostelium G protein-mediated signaling.Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.ERK2 is essential for the growth of human epithelioid malignant mesotheliomas.IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.ERK pathway activation bidirectionally affects visual recognition memory and synaptic plasticity in the perirhinal cortexExtracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma.The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.MyD88 in DNA repair and cancer cell resistance to genotoxic drugs.BRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells.Increasing 3D Matrix Rigidity Strengthens Proliferation and Spheroid Development of Human Liver Cells in a Constant Growth Factor Environment.Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling.Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration.MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells.Sorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway.The expression and activation of ERK/MAPK pathway in human esophageal cancer cell line EC9706.ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling.Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.ERK2 and JNK1 contribute to TNF-α-induced IL-8 expression in synovial fibroblasts.Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M.The Dictyostelium MAPK ERK1 is phosphorylated in a secondary response to early developmental signaling.Signal transduction disturbance related to hepatocarcinogenesis in mouse by prolonged exposure to Nanjing drinking water.ERK1/2 promotes cigarette smoke-induced rat pulmonary artery smooth muscle cells proliferation and pulmonary vascular remodeling via up-regulating cycline1 expression.Small interfering RNA against ERK1/2 attenuates cigarette smoke-induced pulmonary vascular remodeling.ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation.Dictyostelium Erk2 is an atypical MAPK required for chemotaxis.The complexity of ERK1 and ERK2 MAPKs in multiple hepatocyte fate responses.
P2860
Q24621902-2DC6C31A-06EE-41E2-848E-CF5FF6C47350Q26742080-8BB3E14D-A27B-44E0-AA95-0235D6D8F9F2Q26744787-DC1CF740-83CD-41CB-93BA-2EEAB12ED319Q28474123-0889572B-039A-4A12-8BCF-E4130E2D937EQ28484496-EE405638-804B-4E07-867F-AB7D724D6DE3Q30541429-6870C6E9-72CC-4B28-BF44-03C0E1AC52EFQ33359985-E4C5BD36-1FA0-4DCB-BC0C-489F00F42759Q33517129-6A4E7902-7525-4899-95EA-7EF3F3F77469Q33520834-80E4697B-B820-4C41-A0D9-5D1DCFC5B9FAQ33634659-D79CC767-254B-4136-9F3F-49D393F06809Q33810552-D01AB1A7-39F8-4D7C-8598-AC61DE52DAFAQ33836237-BF4BEB9A-175E-4AB6-8A4E-23FEE39592FFQ34768262-DD0F16C6-574D-42B5-96B8-1108C82A0006Q35529018-4B85E11D-AAD6-4312-8744-98CCCD256D75Q35636272-938F9851-9979-432B-9450-D8DEBD374BA3Q35894374-C3C6F7B9-5B8D-4613-ADAC-1D09762CB1C0Q36362544-B8E7F389-1486-4B16-A99C-04CAFB779131Q36976203-5484D649-EF75-4ABC-825E-33C97B84FBABQ37399265-9C08F678-59F1-4F1D-A47D-6FA75F088322Q38838612-2BC475CD-0D9F-4F29-9E8D-E9A4117FC278Q39004686-4C0BACDA-2B45-491D-9DFF-EDCC2996D8D9Q39150740-6CCB5081-00D2-4CD2-9061-47711E39357CQ39215469-EF1BB612-F669-4A2F-8C6F-E09851618859Q39264596-0A37BF94-7D7B-4016-B8E7-E70CA68AD161Q39660386-43ACE9E2-6178-4BD4-B09B-1FAB465B48D9Q39704415-356141BE-A24D-4370-9ED8-DB4FA99043FFQ39778248-56939CFD-FD8C-41A6-B5DB-2099605FBA92Q39846471-7125988A-EB09-4142-B372-A9EDF6FE0638Q41343608-47336130-F916-4A50-AF9D-D19ED5B05048Q41382132-6C226FE6-6CC0-4953-8B60-4FB8144CEF9EQ41521854-36E7834D-8B1F-4F44-BBA2-A8CA75DF7E0BQ43127784-31713EF4-571E-45EF-B1BB-3ECE63027FCCQ43465192-F7DE9327-FBFA-46A9-A223-5D27FBF4DD30Q45354269-4A9A320A-02D9-49AF-A083-5DD96BA961BDQ47104024-69D30FD5-C584-4551-BA64-2362CD004E54Q51179467-6FEB1EC6-7EA8-498D-AE2D-06B1C2E38798Q52689774-84C8EAA2-2854-4A09-9C36-A9ABF1D7FCD0Q54381191-BB19BE6B-884F-43DF-A2FE-A42ECA747D55
P2860
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
@en
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
@nl
type
label
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
@en
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
@nl
prefLabel
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
@en
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2008.163
P407
P577
2008-06-02T00:00:00Z